icon
沙特阿拉伯王国政府所属的官方政府网站。
icon 周四 25 6月 2026
icon
沙特官方政府网站的域名以下列后缀结尾 gov.sa

沙特阿拉伯王国所有政府机构的官方网站均以 .gov.sa 结尾。

icon
政府网站使用以下协议。 HTTPS 用于加密和安全。

沙特阿拉伯王国所有政府机构的官方网站均以 .gov.sa 结尾。

icon
在数字政府管理局注册,编号:
20250831619
建议

الرسائل الموجهة للمختصين الصحيين

المنتج التاريخ معلومات السلامة المرفقات
Sclera (Dimethyl fumarate)

Updated recommendations in the light of cases of progressive multifocal leukoencephalopathy (PML) in the setting of mild lymphopenia.

Defra (Dimethyl fumarate)

Updated recommendations in the light of cases of progressive multifocal leukoencephalopathy (PML) in the setting of mild lymphopenia.

Fingolimod SPC (fingolimod)

Updated recommendations to minimize the risk of drug-induced liver injury (DILI).

Tecfidera (dimethyl fumarate)

Updated recommendations in the light of cases of progressive multifocal leukoencephalopathy (PML) in the setting of mild lymphopenia

Gilenya (fingolimod)

Updated recommendations to minimize the risk of drug-induced liver injury (DILI)

Haldol (Haloperidol)

HALDOL® 5mg/ml (HALOPERIDOL) solution for injection: Incorrect information on route of administration on outer carton

Esbriet (pirfenidone)

Esbriet (pirfenidone): Important safety update and new recommendations to prevent Drug-Induced Liver Injury (DILI)

Levon (Levofloxacin Hemihydrate) / Moxiflox (Moxifloxacin)

Systemic and inhaled fluoroquinolones: warning about new risk of heart valve regurgitation/incompetence.

Tarivid (Ofloxacin) / Tavanic (Levofloxacin)

Systemic and inhaled fluoroquinolones: warning about new risk of heart valve regurgitation/incompetence.

Revlimid® (Lenalidomide)

Notification of typographical error in the Revlimid® (Lenalidomide) Hard Capsules Patient Information Leaflet (PIL)